Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Liabilities from Discontinued Operations: 2017-2022

Historic Liabilities from Discontinued Operations for Lifecore Biomedical (LFCR) over the last 4 years, with May 2022 value amounting to $4.7 million.

  • Lifecore Biomedical's Liabilities from Discontinued Operations fell 94.11% to $518,000 in Q1 2023 from the same period last year, while for Feb 2023 it was $518,000, marking a year-over-year decrease of 94.11%. This contributed to the annual value of $4.7 million for FY2022, which is 90.41% down from last year.
  • Per Lifecore Biomedical's latest filing, its Liabilities from Discontinued Operations stood at $4.7 million for FY2022, which was down 90.41% from $49.5 million recorded in FY2021.
  • Lifecore Biomedical's Liabilities from Discontinued Operations' 5-year high stood at $49.5 million during FY2021, with a 5-year trough of $458,000 in FY2018.
  • In the last 2 years, Lifecore Biomedical's Liabilities from Discontinued Operations had a median value of $27.1 million in 2021 and averaged $27.1 million.
  • Data for Lifecore Biomedical's Liabilities from Discontinued Operations shows a maximum YoY tumbled of 90.41% (in 2022) over the last 5 years.
  • Lifecore Biomedical's Liabilities from Discontinued Operations (Yearly) stood at $458,000 in 2018, then reached $49.5 million in 2021, then tumbled by 90.41% to $4.7 million in 2022.